Background: Achieving and maintaining adequate glycaemic control is critical to reduce diabetes-related complications. Therapeutic inertia is one of the leading causes of suboptimal glycaemic control.
Aim: To assess the degree of inertia in insulin initiation and intensification in people with Type 2 diabetes mellitus (DM-2).